DiCello Levitt and its attorneys were once again recognized by Benchmark Litigation across numerous categories in the prestigious legal research organization’s 2024 rankings. Benchmark Litigation listed DiCello Levitt as a top plaintiffs’ firm in the United States, a nationwide leader in competition and antitrust litigation, and a recommended firm in Alabama, Illinois, New York, and Ohio.
The following firm partners were individually recognized as Litigation Stars for their work in various practice areas:
Benchmark Litigation conducts extensive research on the firms and attorneys it recognizes. It interviews lawyers, dispute resolution specialists, and clients to identify the premier litigators and law firms across the United States. Topics of these interviews include the nominees’ recent casework and colleagues’ professional opinions.
“In the six years since its inception in 2017, DiCello Levitt has made considerable headway in distinguishing itself in the crowded field of plaintiff firms,” Benchmark’s editorial team wrote. “The firm, staffed by a broad range of area specialists, is recognized for its diverse arsenal of litigation capabilities across numerous practice areas, a unique trait among firms of its size. DiCello Levitt’s practitioners are applauded by clients for their ‘strong, enthusiastic, and dedicated approach to representation’ and for ‘going the extra step to present the best solutions possible.’”
The editorial team commended Co-Founding Partners Mark DiCello and Adam Levitt, noting Mark’s “personal injury and mass tort expertise” and highlighting Adam’s instrumental work in several high-stakes automotive and pharmaceutical class actions. They also recognized Amy Keller, chair of DiCello Levitt’s Privacy, Technology, and Cybersecurity Practice Group, for her work securing a $21 million class action settlement in a case concerning deceptive labeling and marketing of Fairlife milk products—among the highest animal welfare, food products case settlements ever. Diandra “Fu” Debrosse Zimmermann, Birmingham office managing partner and mass tort division co-chair, was recognized for taking “infant formula entities Abbott and Mead Johnson to task, representing a class of families who suffered premature infant births owing to the defendants’ formulas greatly increasing the risk of a severe gastrointestinal disorder that causes intestinal tissue death and can be fatal.”
For more on DiCello Levitt’s Benchmark Litigation analysis, visit the firm’s profile.